Who is sponsoring NCT03685526?

NCT03685526 is sponsored by Lifetech Scientific (Shenzhen) Co., Ltd..

What drugs are being tested in NCT03685526?

Interventions in NCT03685526: Cinenses Lung Volume Reduction Reverser System.

Is NCT03685526 still recruiting?

NCT03685526 is currently status unknown. Last updated 29 June 2021.

Last reviewed 2021-06-29 · How we verify

NCT03685526

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cinenses Lung Volume Reduction Reverser System First-in-man Study Treating Patients With Severe Emphysema

Status unknown NA Last updated 29 June 2021

What this trial tests

NA trial testing Cinenses Lung Volume Reduction Reverser System in Emphysema in 15 participants. Status unknown.

Timeline

6 May 2019

Primary endpoint
1 October 2021

1 August 2022

Quick facts

Lead sponsor	Lifetech Scientific (Shenzhen) Co., Ltd.
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	15
Start date	6 May 2019
Primary completion	1 October 2021
Estimated completion	1 August 2022
Sites	1 location across Germany

Drugs / interventions tested

Cinenses Lung Volume Reduction Reverser System

Conditions studied

Emphysema — all drugs for Emphysema →

Sponsor

Lifetech Scientific (Shenzhen) Co., Ltd. — full company profile →

Who can join

Adults 50 to 80, any sex, with Emphysema. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is designed as a prospective, nonrandomized, exploratory, single center, first-in-man study. The objective of this study is to evaluate its safety and feasibility of the CinensesTM Lung Volume Reduction Reverser System in patients with severe emphysema. The study will also collect clinical data up to 6-month follow-up to explore its safety and effectiveness.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Bronchoscopic Lung Volume Reduction Coil Treatment for Severe Emphysema: A Systematic Review and Meta-Analysis of Individual Participant Data.
Roodenburg SA, Hartman JE, Deslée G, Herth FJF, et al · · 2022 · cited 16× · PMID 35405678 · DOI 10.1159/000524148
Surgical and bronchoscopic pulmonary function-improving procedures in lung emphysema.
Everaerts S, Vandervelde CM, Shah P, Slebos DJ, et al · · 2023 · cited 10× · PMID 38123230 · DOI 10.1183/16000617.0004-2023
ERJ Advances: interventional bronchoscopy.
Garner JL, Shah PL, Herth F, Slebos DJ. · · 2024 · cited 3× · PMID 38991719 · DOI 10.1183/13993003.01946-2023

Verify or expand the search:

Other recruiting trials for Emphysema

Currently open trials in the same condition.

NCT07059637 — Implementation of a Sarcopenia Clinic to Diagnose and Treat Skeletal Muscle Loss Due to COPD · NA · recruiting
NCT06891755 — Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3 · NA · recruiting
NCT06025500 — Analysing Peripheral Skeletal Muscle Function Before and After Endobronchial Valve Treatment · recruiting
NCT06533371 — Clinical-ultrasonographic Assessment of Pulmonary Emphysema · NA · recruiting
NCT06528418 — Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath · recruiting

Other Lifetech Scientific (Shenzhen) Co., Ltd. trials

Trials by the same sponsor.

NCT07385599 — FIM Study of the LAmbre™ II LAA Occluder in Non-Valvular AF Patients · NA · active not recruiting
NCT06915545 — Study on the Aortic Arch Single Branch Stent Graft System · NA · recruiting
NCT06849635 — Cera™ ASD Occluder Post-Market Clinical Follow-Up Study · recruiting
NCT06700174 — Lifetech AcuMark™ Sizing Balloon Post-Market Clinical Follow-up Study · recruiting
NCT06520774 — Concave Supra-arch Branched Stent-Graft System for Endovascular Treatment of Aortic Arch Diseases · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03685526 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Lifetech Scientific (Shenzhen) Co., Ltd.
Last refreshed: 29 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03685526.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing